Sacituzumab govitecan (anti-TROP2) - Primary antibody, specific to TACSTD2, >90% (SDS-PAGE&SEC), high purity, Human IgG1, Antibody of tumor associated calcium signal transducer 2

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
Features and benefits
  • Host species: Human
  • Species reactivity(Reacts with): Cynomolgus monkey,Human
  • Isotype: Human IgG1
  • Conjugation: Mc-VC-PAB-SN38
Item Number
Ab175650
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab175650-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$79.90
Ab175650-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$379.90
Ab175650-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$949.90
Ab175650-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,519.90

Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Conjugated (Mc-VC-PAB-SN38)

Basic Description

Product NameSacituzumab govitecan (anti-TROP2) - Primary antibody, specific to TACSTD2, >90% (SDS-PAGE&SEC), high purity, Human IgG1
SynonymsCell surface glycoprotein Trop 2 antibody | Cell surface glycoprotein Trop-2 antibody | Cell surface glycoprotein Trop2 antibody | Epithelial glycoprotein 1 antibody | GA733 1 antibody | GA7331 antibody | M1S 1 antibody | M1S1 antibody | Membrane componen
Specifications & PurityCarrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot
Biochemical and Physiological MechanismsMay function as a growth factor receptor.
Host speciesHuman
SpecificityTACSTD2
ConjugationMc-VC-PAB-SN38
GradeAzide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action TypeBINDING AGENT
Mechanism of actionAntibody of tumor associated calcium signal transducer 2
Product Description

Sacituzumab govitecan (anti-TROP2) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan (anti-TROP2) shows anticancer activity.

Product Properties

IsotypeHuman IgG1
Light Chain Typekappa
SDS-PAGE145 kDa
Purification MethodProtein A purified
Purity>90% (SDS-PAGE&SEC)
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -80°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS1491917-83-9

Associated Targets(Human)

TACSTD2 Tclin Tumor-associated calcium signal transducer 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Stoyanova T, Goldstein AS, Cai H, Drake JM, Huang J, Witte ON.  (2012)  Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via β-catenin signaling..  Genes Dev,  26  (20): (2271-85).  [PMID:23070813] [10.1021/op500134e]
2. Ocean AJ, Starodub AN, Bardia A, Vahdat LT, Isakoff SJ, Guarino M, Messersmith WA, Picozzi VJ, Mayer IA, Wegener WA et al..  (2017)  Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics..  Cancer,  123  (19): (3843-3854).  [PMID:28558150] [10.1021/op500134e]
3. Sahota S, Vahdat LT.  (2017)  Sacituzumab govitecan: an antibody-drug conjugate..  Expert Opin Biol Ther,  17  (8): (1027-1031).  [PMID:28503956] [10.1021/op500134e]
4. Stein R, Basu A, Goldenberg DM, Lloyd KO, Mattes MJ.  (1994)  Characterization of cluster 13: the epithelial/carcinoma antigen recognized by MAb RS7..  Int J Cancer Suppl,  (13): (98-102).  [PMID:8194903] [10.1021/op500134e]
5. Stein R, Basu A, Chen S, Shih LB, Goldenberg DM.  (1993)  Specificity and properties of MAb RS7-3G11 and the antigen defined by this pancarcinoma monoclonal antibody..  Int J Cancer,  55  (6): (938-46).  [PMID:8253531] [10.1021/op500134e]

Solution Calculators